Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
0.627
+0.025 (4.22%)
At close: Jul 26, 2024, 4:00 PM
0.621
-0.006 (-0.94%)
After-hours: Jul 26, 2024, 7:20 PM EDT

Bionano Genomics Revenue

Bionano Genomics had revenue of $8.77M in the quarter ending March 31, 2024, with 18.26% growth. This brings the company's revenue in the last twelve months to $37.47M, up 26.93% year-over-year. In the year 2023, Bionano Genomics had annual revenue of $36.12M with 29.90% growth.

Revenue (ttm)
$37.47M
Revenue Growth
+26.93%
P/S Ratio
1.35
Revenue / Employee
$108,924
Employees
344
Market Cap
50.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.12M8.31M29.90%
Dec 31, 202227.80M9.82M54.62%
Dec 31, 202117.98M9.48M111.47%
Dec 31, 20208.50M-1.63M-16.06%
Dec 31, 201910.13M-1.87M-15.59%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 552.74M
Atara Biotherapeutics 34.70M
LAVA Therapeutics 13.63M
MSP Recovery 9.71M
Lexaria Bioscience 376.85K
Revenue Rankings